Is lateral epicondylitis a new indication for botulinum toxin?

CMAJ. Canadian Medical Association Journal

Volumn 182, Issue 8, 2010, Pages 749-750

  Buchbinder, Rachelle ^a   Richards, Bethan L ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; GLYCERYL TRINITRATE; PLACEBO; SCLEROSING AGENT;

ANALGESIC ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EXTENSOR MUSCLE; GRIP STRENGTH; HEALTH CARE COST; HUMAN; ISOMETRIC EXERCISE; NOTE; OUTCOME ASSESSMENT; PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TENNIS ELBOW; THROMBOCYTE RICH PLASMA; TREATMENT DURATION;

EID: 77953317381     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100358     Document Type: Note

References (13)

1. Walker-Bone K, Palmer K, Reading I, et al. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum 2004;51:642-651
2. Fan ZJ, Silverstein BA, Bao S, et al. Quantitative exposure-response relations between physical workload and prevalence of lateral epicondylitis in a working population. Am J Ind Med 2009;52:479-490
3. Johnson GW, Cadwallader K, Scheffel SB, et al. Treatment of lateral epicondylitis. Am Fam Physician 2007;76:843-848
4. Smidt N, Lewis M, Van Der Windt DAWM, et al. Lateral epicondylitis in general practice: course and prognostic indicators of outcome. J Rheumatol 2006;33:2053-2059 (Pubitemid 44571882)
5. Espandar R, Heidari P, Rasouli MR, et al. Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial. CMAJ 2010;182:768-773
6. Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol 2004;251(Suppl 1):1-7. (Pubitemid 38299759)
7. Hayton MJ, Santini AJ, Hughes PJ, et al. Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled, pilot study. J Bone Joint Surg Am 2005;87:503-507
8. Wong SM, Hui AC, Tong PY, et al. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2005;143:793-797
9. Placzek R, Drescher W, Deuretzbacher G, et al. Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study. J Bone Joint Surg Am 2007;89:255-260
10. Smidt N, van der Windt DA, Assendelft WJ, et al. Interobserver reproducibility of the assessment of severity of complaints, grip strength, and pressure pain threshold in patients with lateral epicondylitis. Arch Phys Med Rehabil 2002;83:1145-1150
11. Paoloni JA, Murrell GAC, Burch RM, et al. Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis. Br J Sports Med 2009;43:299-302.
12. Rabago D, Best TM, Zgierska AE, et al. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med 2009;43:471-481
13. Connell D, Datir A, Alyas F, et al. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med 2009;43:293-298